-
-
-
-
-
-
-
RedHill explores opaganib for ebola outbreak response
-
-
-
-
-
-
-
RedHill advances RHB-102 development for GLP-1 side effects
-
-
-
-
-
-
-
RedHill wins $10.5 million court judgment against Kukbo Co.
-
-
-
-
-
-
-
RedHill licenses Talicia to Middle East partner for $1.8M deal
-
-
-
-
-
-
-
RedHill receives $1.1 million in licensing payments for Talicia
-
-
-
-
-
-
-
RedHill-Supported Medscape H. Pylori Educational Program to Launch at Major Gastroenterology Congress
-
-
-
-
-
-
-
RedHill Biopharma Announces Full-Year 2024 Financial Results and Operational Highlights
-
1,162,306 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

